46 related articles for article (PubMed ID: 30449641)
1. Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
Rule S; Dreyling M; Goy A; Hess G; Auer R; Kahl B; Cavazos N; Liu B; Yang S; Clow F; Goldberg JD; Beaupre D; Vermeulen J; Wildgust M; Wang M
Br J Haematol; 2017 Nov; 179(3):430-438. PubMed ID: 28832957
[TBL] [Abstract][Full Text] [Related]
2. Adding ibrutinib to frontline therapy improves outcomes in transplant-eligible patients with MCL.
Killock D
Nat Rev Clin Oncol; 2024 Jul; 21(7):483. PubMed ID: 38789564
[No Abstract] [Full Text] [Related]
3. Iris Melanocytoma with Minimal Change over 50 Years.
Card KR; Barke MR; Shields JA
Ophthalmology; 2023 Dec; 130(12):1350. PubMed ID: 36922338
[No Abstract] [Full Text] [Related]
4. Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma.
Agarwal R; Chan YC; Tam CS; Hunter T; Vassiliadis D; Teh CE; Thijssen R; Yeh P; Wong SQ; Ftouni S; Lam EYN; Anderson MA; Pott C; Gilan O; Bell CC; Knezevic K; Blombery P; Rayeroux K; Zordan A; Li J; Huang DCS; Wall M; Seymour JF; Gray DHD; Roberts AW; Dawson MA; Dawson SJ
Nat Med; 2019 Jan; 25(1):119-129. PubMed ID: 30455436
[TBL] [Abstract][Full Text] [Related]
5. Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.
Park SS; Eom HS; Kim JS; Koh Y; Choi CW; Lee JJ; Kim K; Suh C; Lee JH; Min CK;
Jpn J Clin Oncol; 2019 Jan; 49(1):92-95. PubMed ID: 30476124
[TBL] [Abstract][Full Text] [Related]
6. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.
Cheng MP; Kusztos AE; Gustine JN; Dryden-Peterson SL; Dubeau TE; Woolley AE; Hammond SP; Baden LR; Treon SP; Castillo JJ; Issa NC
Br J Haematol; 2019 May; 185(4):788-790. PubMed ID: 30460682
[No Abstract] [Full Text] [Related]
7. Is less equal with ibrutinib dose?
Rogers KA
Blood; 2018 Nov; 132(21):2211-2212. PubMed ID: 30467185
[No Abstract] [Full Text] [Related]
8. Ibrutinib for mantle cell lymphoma.
Tucker DL; Rule SA
Future Oncol; 2016 Feb; 12(4):477-91. PubMed ID: 26759179
[TBL] [Abstract][Full Text] [Related]
9. Ibrutinib (Imbruvica). Relapsed chronic lymphocytic leukaemia and mantle cell lymphoma: uncertain impact on survival.
January
Prescrire Int; 2016 Apr; 25(170):89-92. PubMed ID: 27183765
[TBL] [Abstract][Full Text] [Related]
10. [Mantle cell lymphoma of the iris treated by ibrutinib].
Sales De Gauzy T; Oberic L; Fournié P; Soler V
J Fr Ophtalmol; 2018 Dec; 41(10):e501-e502. PubMed ID: 30449641
[No Abstract] [Full Text] [Related]
11. Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy.
Nishiyama-Fujita Y; Nakazato T; Ito C; Ogura S; Mizuno K; Kamiya T; Aisa Y; Mori T
Intern Med J; 2019 Sep; 49(9):1187-1189. PubMed ID: 31507052
[No Abstract] [Full Text] [Related]
12. Ibrutinib-associated Serositis in Mantle Cell Lymphoma.
Styskel BA; Lopez-Mattei J; Jimenez CA; Stewart J; Hagemeister FB; Faiz SA
Am J Respir Crit Care Med; 2019 Jun; 199(12):e43-e44. PubMed ID: 30802411
[No Abstract] [Full Text] [Related]
13. Treatment response of cutaneous mantle cell lymphoma to ibrutinib and radiotherapy.
Mancebo SE; Smith JR; Intlekofer AM; Zelenetz AD; Myskowski PL
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e113-5. PubMed ID: 25499623
[No Abstract] [Full Text] [Related]
14. Ibrutinib--a new standard treatment for relapsed mantle cell lymphoma?
Martin P
Lancet; 2016 Feb; 387(10020):728-9. PubMed ID: 26673812
[No Abstract] [Full Text] [Related]
15. Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma.
Maruyama D; Nagai H; Fukuhara N; Kitano T; Ishikawa T; Nishikawa T
J Clin Exp Hematop; 2019; 59(2):98-100. PubMed ID: 31257351
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
